Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil
Genre
Journal articleDate
2021-05-21Author
Faria, Nuno R.Mellan, Thomas A.
Whittaker, Charles
Claro, Ingra M.
Candido, Darlan da S.
Mishra, Swapnil
Crispim, Myuki A. E.
Sales, Flavia C.S.
Hawryluk, Iwona
McGrone, John T.
Hulswit, Ruben J.G.
Franco, Lucas A.M.
Ramundo, Mariana S.
De Jesus, Jaqueline G.
Andrade, Pamela S.
Coletti, Thais M.
Ferreira, Giulia M.
Silva, Camila A.M.
Manuli, Erika R.
Pereira, Rafael H.M.
Peixoto, Pedro S.
Kraemaer, Moritz U.G.
Gaburo Jr., Nelson
Camilo, Cecilia da C.
Hoeltgebaum, Henrique
Souza, William M.
Rocha, Esmenia C.
de Souza, Leandro M.
de Pinho, Mariana C.
Araujo, Leonardo J.T.
Malta, Frederico S.V.
de Lima, Aline B.
Silva, Joice do P.
Zauli, Danielle A.G.
Ferreira, Alessandro C. de S.
Schnekenberg, Ricardo P.
Laydon, Daniel J.
Walker, Patrick G.T.
Schluter, Hannah M.
dos Santos, Ana L.P.
Vidal, Maria S.
Del Caro, Valentina S.
Filho, Rosinaldo M.F.
dos Santos, Helem M.
Aguiar, Renato S.
Proenca-Modena, Jose L.
Nelson, Bruce
Hay, James A.
Monod, Melodie
Miscouridou, Xenia
Coupland, Helen
Sonabend, Raphael
Vollmer, Michaela
Gandy, Axel
Prete Jr., Carlos A.
Nascimento, Vitor H.
Suchard, Marc A.
Bowden, Thomas A.
Pond, Sergei
Wu, Chieh-Hsi
Ratmann, Oliver
Ferguson, Neil M.
Dye, Christopher
Loman, Nick J.
Lemey, Philippe
Rambaut, Andrew
Fraiji, Nelson A.
Carvalho, Maria do P.S.S.
Pybus, Oliver G.
Flaxman, Seth
Bhatt, Samir
Sabino, Ester C.
Department
BiologyPermanent link to this record
http://hdl.handle.net/20.500.12613/7042
Metadata
Show full item recordDOI
https://doi.org/10.1126/science.abh2644Abstract
Cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in Manaus, Brazil, resurged in late 2020 despite previously high levels of infection. Genome sequencing of viruses sampled in Manaus between November 2020 and January 2021 revealed the emergence and circulation of a novel SARS-CoV-2 variant of concern. Lineage P.1 acquired 17 mutations, including a trio in the spike protein (K417T, E484K, and N501Y) associated with increased binding to the human ACE2 (angiotensin-converting enzyme 2) receptor. Molecular clock analysis shows that P.1 emergence occurred around mid-November 2020 and was preceded by a period of faster molecular evolution. Using a two-category dynamical model that integrates genomic and mortality data, we estimate that P.1 may be 1.7- to 2.4-fold more transmissible and that previous (non-P.1) infection provides 54 to 79% of the protection against infection with P.1 that it provides against non-P.1 lineages. Enhanced global genomic surveillance of variants of concern, which may exhibit increased transmissibility and/or immune evasion, is critical to accelerate pandemic responsiveness.Citation to related work
American Association for the Advancement of ScienceHas part
Science, Vol. 372ADA compliance
For Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.eduae974a485f413a2113503eed53cd6c53
http://dx.doi.org/10.34944/dspace/7023